AJCN Tufts Nutrition Symposium, Boston Sept 24-26
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jenkins, D. J.
Right arrow Articles by Corey, P. N
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jenkins, D. J.
Right arrow Articles by Corey, P. N
Agricola
Right arrow Articles by Jenkins, D. J.
Right arrow Articles by Corey, P. N
American Journal of Clinical Nutrition, Vol. 75, No. 5, 834-839, May 2002
© 2002 American Society for Clinical Nutrition


Original Research Communication

Soluble fiber intake at a dose approved by the US Food and Drug Administration for a claim of health benefits: serum lipid risk factors for cardiovascular disease assessed in a randomized controlled crossover trial1,2,3

David JA Jenkins, Cyril WC Kendall, Vladimir Vuksan, Edward Vidgen, Tina Parker, Dorothea Faulkner, Christine C Mehling, Marcella Garsetti, Giulio Testolin, Stephen C Cunnane, Mary Ann Ryan and Paul N Corey

1 From the Clinical Nutrition and Risk Factor Modification Center, St Michael'sHospital, Toronto (DJAJ, CWCK, VV, EV, TP, DF, and CCM); the Departments of Nutritional Sciences (DJAJ, CWCK, VV, EV, SCC, and MAR) and Preventive Medicine and Biostatistics (PNC), Faculty of Medicine, University of Toronto; and the Department of Food Science Technology and Microbiology, Division of Human Nutrition, University of Milan, Milan, Italy (MG and GT).

Background: The US Food and Drug Administration (FDA) approved health claims for 2 dietary fibers, ß-glucan (0.75 g/serving) and psyllium (1.78 g/serving), on the assumption that 4 servings/d would reduce cardiovascular disease risk.

Objective: We assessed the efficacy of this dose of fibers in reducing serum lipid risk factors for cardiovascular disease.

Design: Sixty-eight hyperlipidemic adults consumed a test (high-fiber) and a control low-fat (25% of energy), low-cholesterol (<150 mg/d) diet for 1 mo each in a randomized crossover study. The high-fiber diet included 4 servings/d of foods containing ß-glucan or psyllium that delivered 8 g/d more soluble fiber than did similar, unsupplemented foods in the control diet. Fasting blood samples and blood pressure readings were obtained at baseline and weeks 2 and 4, and the subjects' weight was monitored weekly.

Results: Compared with the control diet, the high-fiber diet reduced total cholesterol (2.1 ± 0.7%; P = 0.003), total:HDL cholesterol (2.9 ± 0.8%; P = 0.001), LDL:HDL cholesterol (2.4 ± 1.0%; P = 0.015), and apolipoprotein B:A-I (1.4 ± 0.8%; P = 0.076). Applying the Framingham cardiovascular disease risk equation to the data confirmed a reduction in risk of 4.2 ± 1.4% (P = 0.003). Small reductions in blood pressure were found after both diets. The subjects reported no significant differences in palatability or gastrointestinal symptoms between the diets.

Conclusions: The reduction in serum lipid risk factors for cardiovascular disease supports the FDA'sapproval of a health claim for a dietary fiber intake of 4 servings/d. Although relatively small in terms of patient treatment, the reduction in cardiovascular disease risk is likely to be significant on a population basis.

Key Words: Soluble fiber • psyllium • oats • ß-glucan • LDL cholesterol • HDL cholesterol • coronary artery disease • National Cholesterol Education Program • Food and Drug Administration • health claim • functional foods




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
E. A. Murphy, J. M. Davis, A. S. Brown, M. D. Carmichael, J. A. Carson, N. Van Rooijen, A. Ghaffar, and E. P. Mayer
Benefits of oat {beta}-glucan on respiratory infection following exercise stress: role of lung macrophages
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2008; 294(5): R1593 - R1599.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. M Zivkovic, J B. German, and A. J Sanyal
Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease
Am. J. Clinical Nutrition, August 1, 2007; 86(2): 285 - 300.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. E. Griel, E. H. Ruder, and P. M. Kris-Etherton
The Changing Roles of Dietary Carbohydrates: From Simple to Complex
Arterioscler. Thromb. Vasc. Biol., September 1, 2006; 26(9): 1958 - 1965.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
I. A Castro, L. P Barroso, and P. Sinnecker
Functional foods for coronary heart disease risk reduction: a meta-analysis using a multivariate approach
Am. J. Clinical Nutrition, July 1, 2005; 82(1): 32 - 40.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
K. M Behall, D. J Scholfield, and J. Hallfrisch
Diets containing barley significantly reduce lipids in mildly hypercholesterolemic men and women
Am. J. Clinical Nutrition, November 1, 2004; 80(5): 1185 - 1193.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
D. L. Katz, M. A. Evans, W. Chan, H. Nawaz, B. P. Comerford, M. L. Hoxley, V. Y. Njike, and P. M. Sarrel
Oats, Antioxidants and Endothelial Function in Overweight, Dyslipidemic Adults
J. Am. Coll. Nutr., October 1, 2004; 23(5): 397 - 403.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
E. A. Murphy, J. M. Davis, A. S. Brown, M. D. Carmichael, E. P. Mayer, and A. Ghaffar
Effects of moderate exercise and oat {beta}-glucan on lung tumor metastases and macrophage antitumor cytotoxicity
J Appl Physiol, September 1, 2004; 97(3): 955 - 959.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. T. Kappagoda, D. A. Hyson, and E. A. Amsterdam
Low-carbohydrate-high-protein diets: Is there a place for them in clinical cardiology?
J. Am. Coll. Cardiol., March 3, 2004; 43(5): 725 - 730.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
M. A. Pereira, E. O'Reilly, K. Augustsson, G. E. Fraser, U. Goldbourt, B. L. Heitmann, G. Hallmans, P. Knekt, S. Liu, P. Pietinen, et al.
Dietary Fiber and Risk of Coronary Heart Disease: A Pooled Analysis of Cohort Studies
Arch Intern Med, February 23, 2004; 164(4): 370 - 376.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
K. M. Behall, D. J. Scholfield, and J. Hallfrisch
Lipids Significantly Reduced by Diets Containing Barley in Moderately Hypercholesterolemic Men
J. Am. Coll. Nutr., February 1, 2004; 23(1): 55 - 62.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. M. Davis, E. A. Murphy, A. S. Brown, M. D. Carmichael, A. Ghaffar, and E. P. Mayer
Effects of moderate exercise and oat {beta}-glucan on innate immune function and susceptibility to respiratory infection
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2004; 286(2): R366 - R372.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by The American Society for Nutrition